gastroparesis and glp 1 drugs GLP-1 Gastroparesis: What Patients Should Know? TrimRX | GLP-1 vs GIP:

For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs

The retatrutide dosing protocol follows a similar escalation pattern to tirzepatide, starting low and increasing over several months

Further studies are warranted to assess the exact site of absorption and the optimal dosage for the desired action with tolerable adverse effects

Mechanism of action Insulin glargine (Toujeo) works by directly providing exogenous insulin to the body

JW: Investigation, Supervision, Writingreview and editing

230,231 By modulating the activity of K-ATP channels, GLP-1 indirectly controls the calcium signaling in -cells, thereby influencing glucagon secretion